Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Built in Partnership Potential - Re: Lead Compound NP-160 Significantly Reduces NALFD Score and Fibrosis in Non-Alcoholic Fatty Liver Disease

Because the drugs chosen by Nash Pharma for screening have already been approved for human use, the original manufacturer of the drug represents a natural built in partnering opportunity. Nash Pharma has already begun the process to develop an outreach strategy to communicate with selected manufacturers of the 7 drug candidates that showed promising data in recent animal in vivo studies.

https://breathtecbiomedical.com/2018/09/13/breathtec-provides-nash-pharmaceuticals-plans-for-next-year/

My best guess for a potential partnership regarding Lead Compound NP-160 goes to...

Boehringer Ingelheim (Founded 1885)

https://www.boehringer-ingelheim.com/

Boehringer Ingelheim works in human pharmaceuticals, animal health, and biopharmaceuticals. The group consists of 145 affiliated companies with around 50,000 employees in 2017 in all continents. Research and development facilities were in five sites and 20 production plants in 13 countries. The research and development facilities are located in Biberach (Germany), Ridgefield (Connecticut), Vienna, Kobe, and Milan (closed in 2017). Over 8,000 employees work for Boehringer Ingelheim in research and development.

Annual Revs: $18.1 Billion EUR/$20.7 Billion USD/$27.5 Billion CAD

https://en.wikipedia.org/wiki/Boehringer_Ingelheim

/////AMG